Polaryx Therapeutics, Inc. (PLYX)
$0.00+$0.00 (+0.00%) Latest sessionExtended Hours
G. Michael Landis - OfficerPolaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.
No Form 4 activity for PLYX in the last 90 days.
2 Form 4 filings on record, the earliest from Feb 20, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Alex Keun Mo Yang - Officer | Open-market purchase | Common Stock | 88,453 | $4.07 | $360K | |
| G. Michael Landis - Officer | Open-market purchase | Common Stock | 2,867 | $2.79 | $8K |
Polaryx Therapeutics, Inc. (PLYX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-29. The full record for PLYX runs to 2 Form 4 filings, the earliest from 2026-02-20. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of PLYX were filed in the last 90 days. 2 purchases are on record for this company.
No insider sales of PLYX were filed in the last 90 days.
This page tracks PLYX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add PLYX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
